<DOC>
	<DOCNO>NCT01222702</DOCNO>
	<brief_summary>Subjects Clostridium Difficile Infection ( CDI ) randomize treat study drug 10 day . At end treatment , cure assess ; subject followed-up assess disease recurrence .</brief_summary>
	<brief_title>ACT-179811 Patients With Clostridium Difficile Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>male female least 18 year old CDI 1st occurrence 1st recurrence concurrent life threaten condition concomitant antimicrobial treatment CDI concomitant treatment another investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>CDIFF</keyword>
	<keyword>CDI</keyword>
	<keyword>CDAD</keyword>
	<keyword>Clostridium difficile infection</keyword>
</DOC>